Dr. Tea Gamezardashvili (MD, PhD, MHA, FACC) is a preventive cardiologist and lipidologist whose clinical and academic work focuses on cardiovascular risk assessment beyond standard reference ranges. She serves as President of the Georgian Atherosclerosis Association (GAA) and as National Coordinator of the EAS Lipid Clinic Network in Georgia, connecting her national practice to the European Atherosclerosis Society's broader clinical network. In 2026, she co-authored an EAS Consensus Paper published in *Atherosclerosis*, contributing to the guideline literature that underpins her clinical approach.
Her central clinical observation — that patients are routinely reassured by "normal" lab values that are not necessarily *optimal* for long-term cardiovascular risk, particularly around ApoB and Lp(a) — led her to found CardioIQ, a physician-authored platform that reads existing lab panels against longevity-optimal, ESC/EAS-anchored targets. The platform is built to support the conversation between patient and physician, not replace it.
Dr. Gamezardashvili works and communicates in English, Georgian, and Russian, giving her direct reach across European, Eurasian, and international medical communities. She is based in Tbilisi, Georgia.
Dr. Tea Gamezardashvili (MD, PhD, MHA, FACC) is a preventive cardiologist and lipidologist whose clinical and academic work focuses on cardiovascular risk assessment beyond standard reference ranges. She serves as President of the Georgian Atherosclerosis Association (GAA) and as National Coordinator of the EAS Lipid Clinic Network in Georgia, connecting her national practice to the European Atherosclerosis Society's broader clinical network. In 2026, she co-authored an EAS Consensus Paper published in *Atherosclerosis*, contributing to the guideline literature that underpins her clinical approach.
Her central clinical observation — that patients are routinely reassured by "normal" lab values that are not necessarily *optimal* for long-term cardiovascular risk, particularly around ApoB and Lp(a) — led her to found CardioIQ, a physician-authored platform that reads existing lab panels against longevity-optimal, ESC/EAS-anchored targets. The platform is built to support the conversation between patient and physician, not replace it.
Dr. Gamezardashvili works and communicates in English, Georgian, and Russian, giving her direct reach across European, Eurasian, and international medical communities. She is based in Tbilisi, Georgia.